Post-tuberculosis treatment paradoxical reactions

Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during treatment, but have also been described after treatment. A presentation with recurrent signs or symptoms of TB after cure or completion of prior treatment needs to be differentiated between microbiological relapse and a para...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Infection Ročník 52; číslo 5; s. 2083 - 2095
Hlavní autoři:	Hermans, Sabine M., Akkerman, Onno W., Meintjes, Graeme, Grobusch, Martin P.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2024 Springer Nature B.V
Témata:	Antitubercular Agents - therapeutic use Central nervous system Chemical synthesis Diagnosis Epidemiology Family Medicine Female General Practice Humans Incidence Infectious Diseases Inflammation Internal Medicine Lymph nodes Male Medicine Medicine & Public Health Recurrence Review Signs and symptoms Tuberculosis Tuberculosis - diagnosis Tuberculosis - drug therapy Tuberculosis - epidemiology Tuberculosis, Lymph Node - diagnosis Tuberculosis, Lymph Node - drug therapy Recurrence Paradoxical reaction Tuberculosis Lymph node Paradoxical upgrading Paradoxical response
ISSN:	0300-8126, 1439-0973, 1439-0973
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during treatment, but have also been described after treatment. A presentation with recurrent signs or symptoms of TB after cure or completion of prior treatment needs to be differentiated between microbiological relapse and a paradoxical reaction. We searched all published literature on post-treatment PR, and present a synthesis of 30 studies, focusing on the epidemiology, diagnosis and management of this phenomenon. We report an additional case vignette. The majority of studies were of lymph node TB (LN-TB), followed by central nervous system TB (CNS-TB). A total of 112 confirmed and 42 possible post-treatment PR cases were reported. The incidence ranged between 3 and 14% in LN-TB and was more frequent than relapses, and between 0 and 2% in all TB. We found four reports of pulmonary or pleural TB post-treatment PR cases. The incidence did not differ by length of treatment, but was associated with younger age at initial diagnosis, and having had a PR (later) during treatment. Post-treatment PR developed mainly within the first 6 months after the end of TB treatment but has been reported many years later (longest report 10 years). The mainstays of diagnosis and management are negative mycobacterial cultures and anti-inflammatory treatment, respectively. Due to the favourable prognosis in LN-TB recurrent symptoms, a short period of observation is warranted to assess for spontaneous regression. In CNS-TB with recurrent symptoms, immediate investigation and anti-inflammatory treatment with the possibility of TB retreatment should be undertaken.
AbstractList	Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during treatment, but have also been described after treatment. A presentation with recurrent signs or symptoms of TB after cure or completion of prior treatment needs to be differentiated between microbiological relapse and a paradoxical reaction. We searched all published literature on post-treatment PR, and present a synthesis of 30 studies, focusing on the epidemiology, diagnosis and management of this phenomenon. We report an additional case vignette. The majority of studies were of lymph node TB (LN-TB), followed by central nervous system TB (CNS-TB). A total of 112 confirmed and 42 possible post-treatment PR cases were reported. The incidence ranged between 3 and 14% in LN-TB and was more frequent than relapses, and between 0 and 2% in all TB. We found four reports of pulmonary or pleural TB post-treatment PR cases. The incidence did not differ by length of treatment, but was associated with younger age at initial diagnosis, and having had a PR (later) during treatment. Post-treatment PR developed mainly within the first 6 months after the end of TB treatment but has been reported many years later (longest report 10 years). The mainstays of diagnosis and management are negative mycobacterial cultures and anti-inflammatory treatment, respectively. Due to the favourable prognosis in LN-TB recurrent symptoms, a short period of observation is warranted to assess for spontaneous regression. In CNS-TB with recurrent symptoms, immediate investigation and anti-inflammatory treatment with the possibility of TB retreatment should be undertaken. Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during treatment, but have also been described after treatment. A presentation with recurrent signs or symptoms of TB after cure or completion of prior treatment needs to be differentiated between microbiological relapse and a paradoxical reaction. We searched all published literature on post-treatment PR, and present a synthesis of 30 studies, focusing on the epidemiology, diagnosis and management of this phenomenon. We report an additional case vignette. The majority of studies were of lymph node TB (LN-TB), followed by central nervous system TB (CNS-TB). A total of 112 confirmed and 42 possible post-treatment PR cases were reported. The incidence ranged between 3 and 14% in LN-TB and was more frequent than relapses, and between 0 and 2% in all TB. We found four reports of pulmonary or pleural TB post-treatment PR cases. The incidence did not differ by length of treatment, but was associated with younger age at initial diagnosis, and having had a PR (later) during treatment. Post-treatment PR developed mainly within the first 6 months after the end of TB treatment but has been reported many years later (longest report 10 years). The mainstays of diagnosis and management are negative mycobacterial cultures and anti-inflammatory treatment, respectively. Due to the favourable prognosis in LN-TB recurrent symptoms, a short period of observation is warranted to assess for spontaneous regression. In CNS-TB with recurrent symptoms, immediate investigation and anti-inflammatory treatment with the possibility of TB retreatment should be undertaken. Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during treatment, but have also been described after treatment. A presentation with recurrent signs or symptoms of TB after cure or completion of prior treatment needs to be differentiated between microbiological relapse and a paradoxical reaction. We searched all published literature on post-treatment PR, and present a synthesis of 30 studies, focusing on the epidemiology, diagnosis and management of this phenomenon. We report an additional case vignette. The majority of studies were of lymph node TB (LN-TB), followed by central nervous system TB (CNS-TB). A total of 112 confirmed and 42 possible post-treatment PR cases were reported. The incidence ranged between 3 and 14% in LN-TB and was more frequent than relapses, and between 0 and 2% in all TB. We found four reports of pulmonary or pleural TB post-treatment PR cases. The incidence did not differ by length of treatment, but was associated with younger age at initial diagnosis, and having had a PR (later) during treatment. Post-treatment PR developed mainly within the first 6 months after the end of TB treatment but has been reported many years later (longest report 10 years). The mainstays of diagnosis and management are negative mycobacterial cultures and anti-inflammatory treatment, respectively. Due to the favourable prognosis in LN-TB recurrent symptoms, a short period of observation is warranted to assess for spontaneous regression. In CNS-TB with recurrent symptoms, immediate investigation and anti-inflammatory treatment with the possibility of TB retreatment should be undertaken.Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during treatment, but have also been described after treatment. A presentation with recurrent signs or symptoms of TB after cure or completion of prior treatment needs to be differentiated between microbiological relapse and a paradoxical reaction. We searched all published literature on post-treatment PR, and present a synthesis of 30 studies, focusing on the epidemiology, diagnosis and management of this phenomenon. We report an additional case vignette. The majority of studies were of lymph node TB (LN-TB), followed by central nervous system TB (CNS-TB). A total of 112 confirmed and 42 possible post-treatment PR cases were reported. The incidence ranged between 3 and 14% in LN-TB and was more frequent than relapses, and between 0 and 2% in all TB. We found four reports of pulmonary or pleural TB post-treatment PR cases. The incidence did not differ by length of treatment, but was associated with younger age at initial diagnosis, and having had a PR (later) during treatment. Post-treatment PR developed mainly within the first 6 months after the end of TB treatment but has been reported many years later (longest report 10 years). The mainstays of diagnosis and management are negative mycobacterial cultures and anti-inflammatory treatment, respectively. Due to the favourable prognosis in LN-TB recurrent symptoms, a short period of observation is warranted to assess for spontaneous regression. In CNS-TB with recurrent symptoms, immediate investigation and anti-inflammatory treatment with the possibility of TB retreatment should be undertaken.
Author	Hermans, Sabine M. Meintjes, Graeme Grobusch, Martin P. Akkerman, Onno W.
Author_xml	– sequence: 1 givenname: Sabine M. surname: Hermans fullname: Hermans, Sabine M. email: s.m.hermans@amsterdamumc.nl organization: Centre for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Public Health-Global Health, Amsterdam Infection and Immunity, Amsterdam UMC, Location University of Amsterdam, Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, Location University of Amsterdam – sequence: 2 givenname: Onno W. surname: Akkerman fullname: Akkerman, Onno W. organization: Department of Pulmonary Diseases and Tuberculosis, University Medical Centre Groningen, University of Groningen, University Medical Centre Groningen, TB Centre Beatrixoord, University of Groningen – sequence: 3 givenname: Graeme surname: Meintjes fullname: Meintjes, Graeme organization: Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Department of Medicine, University of Cape Town, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London – sequence: 4 givenname: Martin P. surname: Grobusch fullname: Grobusch, Martin P. organization: Centre for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Public Health-Global Health, Amsterdam Infection and Immunity, Amsterdam UMC, Location University of Amsterdam, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Institute of Tropical Medicine, University of Tuebingen, Centre de Recherches Médicales en Lambaréné (CERMEL), Masanga Medical Research Unit (MMRU)
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/38955990$$D View this record in MEDLINE/PubMed
BookMark	eNp9kcFPHCEUxkmjqavtP9BDs4kXL6PvDbAMp8Zs1DYx0YOeCcOAxcwOW2BM-9_LuNtt9eCBQOD3Pb73vkOyN4TBEvIF4RQBxFlCDggV1KwsOp0-kBkyKiuQgu6RGVCAqsF6cUAOU3oEAC6Z-EgOaCM5lxJmBG9DylUeWxvN2Ifk0zxHq_PKDnm-1lF34bc3up-XS5N9GNInsu90n-zn7X5E7i8v7pbfq-ubqx_L8-vKMMFzxRrLOsTOtK0TLTdW05pC0zEHwjVSSsGMFNjVVHcLlA3nYqGdk463tWOU0SPybVN3PbYr25liKOperaNf6fhHBe3V65fB_1QP4UkhMikZLkqFk22FGH6NNmW18snYvteDDWNSFASngjdUFvT4DfoYxjiU_hTFyV0tORbq6_-Wdl7-jrMA9QYwMaQUrdshCGrKTG0yUyUz9ZKZmkTNG5HxWU-zLm35_n0p3UhT-Wd4sPGf7XdUz12Eqpo
CitedBy_id	crossref_primary_10_1177_09246479251353401 crossref_primary_10_1007_s42399_025_01901_8 crossref_primary_10_1007_s12328_025_02213_z crossref_primary_10_7759_cureus_80931 crossref_primary_10_3390_idr17030046 crossref_primary_10_3389_frabi_2025_1570989
Cites_doi	10.1007/s15010-012-0376-9 10.1007/s10072-021-05693-2 10.1179/acb.2007.022 10.1016/j.jinf.2013.07.022 10.1186/s12879-016-1816-4 10.1177/0956462420915394 10.3851/IMP2108 10.2217/fmb.15.9 10.1016/S0954-6111(05)80265-3 10.1007/s10096-023-04564-2 10.1016/S2213-2600(23)00097-8 10.1016/0041-3879(90)90052-A 10.1016/j.medj.2022.07.001 10.1016/S1473-3099(08)70184-1 10.1136/thx.2003.019224 10.5588/ijtld.15.0257 10.1186/s12879-018-3229-z 10.1016/0041-3879(79)90042-4 10.1097/01.md.0000189090.52626.7a 10.1007/s10096-002-0821-2 10.1148/radiol.2242011280 10.2169/internalmedicine.52.0826 10.1183/09031936.00.15119200 10.31729/jnma.8042 10.1007/s10096-003-0940-4 10.1186/1752-1947-7-72 10.5588/ijtld.16.0927 10.1097/MEG.0b013e328350fd4a 10.1016/j.jinf.2010.08.011 10.1016/j.ijtb.2020.08.009 10.2149/tmh.2012-09 10.1128/CMR.00021-18 10.1080/00365540310017267 10.1093/cid/ciaa470 10.1136/thx.2005.044321 10.3389/fmed.2021.715115 10.1016/j.jiac.2016.03.012 10.1128/JCM.01696-17 10.1371/journal.ppat.1003468 10.1016/j.nucmedbio.2017.04.003 10.1086/429317 10.1378/chest.106.6.1896 10.1186/s12879-019-4507-0 10.5578/mb.4358 10.1016/0007-0971(84)90165-7 10.1136/bcr-2012-006262 10.2176/nmc.44.133 10.1136/bmj.290.6475.1106 10.1177/2325957413488170 10.1101/2023.04.03.535218 10.1016/0007-0971(88)90069-1
ContentType	Journal Article
Copyright	The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024
Copyright_xml	– notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7RV 7U9 7X7 7XB 88E 8AO 8C1 8FD 8FI 8FJ 8FK ABUWG AEUYN AFKRA BENPR C1K CCPQU FR3 FYUFA GHDGH H94 K9. KB0 M0S M1P M7N NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS RC3 7X8 5PM
DOI	10.1007/s15010-024-02310-0
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Environmental Sciences and Pollution Management ProQuest One Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database ProQuest Algology Mycology and Protozoology Abstracts (Microbiology C) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Technology Research Database CrossRef MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. url: https://search.proquest.com/nahs sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1439-0973
EndPage	2095
ExternalDocumentID	PMC11499416 38955990 10_1007_s15010_024_02310_0
Genre	Journal Article Review
GroupedDBID	--- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 04C 06C 06D 0R~ 0VY 199 1N0 1SB 203 28- 29I 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEUYN AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BPHCQ BSONS BVXVI C6C CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIHBH EIOEI EJD EMB EMOBN EN4 ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P9S PCD PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW Y6R YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7QL 7U9 7XB 8FD 8FK C1K FR3 H94 K9. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 5PM
ID	FETCH-LOGICAL-c475t-48e4d11dcbbf7b5cea32308d4f07f899974c971d23ad61985576aff9f5b2f4343
IEDL.DBID	7RV
ISICitedReferencesCount	7
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001261194200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0300-8126 1439-0973
IngestDate	Tue Nov 04 02:05:06 EST 2025 Thu Oct 02 06:53:08 EDT 2025 Wed Nov 05 04:14:12 EST 2025 Wed Feb 19 02:11:36 EST 2025 Tue Nov 18 20:47:32 EST 2025 Sat Nov 29 06:02:18 EST 2025 Fri Feb 21 02:37:30 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	5
Keywords	Recurrence Paradoxical reaction Tuberculosis Lymph node Paradoxical upgrading Paradoxical response
Language	English
License	2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c475t-48e4d11dcbbf7b5cea32308d4f07f899974c971d23ad61985576aff9f5b2f4343
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23
OpenAccessLink	https://link.springer.com/10.1007/s15010-024-02310-0
PMID	38955990
PQID	3119852951
PQPubID	29907
PageCount	13
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_11499416 proquest_miscellaneous_3075375839 proquest_journals_3119852951 pubmed_primary_38955990 crossref_primary_10_1007_s15010_024_02310_0 crossref_citationtrail_10_1007_s15010_024_02310_0 springer_journals_10_1007_s15010_024_02310_0
PublicationCentury	2000
PublicationDate	2024-10-01
PublicationDateYYYYMMDD	2024-10-01
PublicationDate_xml	– month: 10 year: 2024 text: 2024-10-01 day: 01
PublicationDecade	2020
PublicationPlace	Berlin/Heidelberg
PublicationPlace_xml	– name: Berlin/Heidelberg – name: Germany – name: New York
PublicationSubtitle	A Journal of Infectious Diseases
PublicationTitle	Infection
PublicationTitleAbbrev	Infection
PublicationTitleAlternate	Infection
PublicationYear	2024
Publisher	Springer Berlin Heidelberg Springer Nature B.V
Publisher_xml	– name: Springer Berlin Heidelberg – name: Springer Nature B.V
References	Yamada, Nishikiori, Fujii, Inomata, Chiba, Hirokawa (CR38) 2013; 7 Hawkey, Yap, Pereira, Moore, Davidson, Pasvol (CR19) 2005; 40 Campbell (CR45) 1990; 71 Theron, Venter, Smith, Esmail, Randall, Sood (CR48) 2018; 56 Barr, Coussens, Irvine, Ritchie, Herbert, Choo-Kang (CR5) 2017; 21 Lee, Cresswell, John, Davidson (CR33) 2012; 24 Armange, Lacroix, Petitgas, Arvieux, Piau-Couapel, Poubeau (CR32) 2023; 42 Park, Lee, Lee, Choi, Kim, Woo (CR20) 2013; 67 Takao, Hanehira, Zenke, Shikama, Igei, Inoue (CR10) 2010; 48 Drain, Bajema, Dowdy, Dheda, Naidoo, Schumacher (CR41) 2018 Cheng, Ho, Lee, Chan, Chan, Woo (CR6) 2002; 21 Keeley, Parkash, Tunbridge, Greig, Collini, McKane (CR56) 2020; 31 Machida, Ishihara, Amano, Otsu (CR23) 2018; 18 Campbell, Dyson (CR12) 1979; 60 Rotaru, Tăban, Ţăroi, Pătraşcu, Popa (CR39) 2015; 56 Geri, Passeron, Heym, Arlet, Pouchot, Capron (CR4) 2013; 41 Khurana, Gupta, Joshi, Goyal, Khurana, Pakhare (CR46) 2021; 68 Lefebvre, Argemi, Meyer, Mootien, Douiri, Sferrazza-Mandala (CR50) 2017; 50 Sarda-Mantel, Kaoutar, Alfaiate, Lopes, Paycha, Benali (CR49) 2021; 8 Kondo, Miyagawa (CR11) 2006; 81 Yu, Cho, Park, Jung, Kim, Lee (CR8) 2015; 19 Brown, Smith, Breen, Ormerod, Mittal, Fisk (CR7) 2016; 16 Nakazono (CR36) 1992; 67 Okazaki, Watanabe, Yoneda, Hara, Nishitsuji, Nishi (CR40) 2016; 22 Saraya, Ariga, Takizawa, Goto (CR37) 2013; 52 Hermans, Zinyakatira, Caldwell, Cobelens, Boulle, Wood (CR47) 2021; 72 Jniene, Soualhi, Bouassel, Nayme, Zahraoui, Iraqi (CR53) 2010; 58 Seok, Jeon, Oh, Choi, Choi, Lee (CR22) 2019; 19 Choi, Jeon, Seo, Park, Park, Hahm (CR17) 2002; 224 Polesky, Grove, Bhatia (CR18) 2005; 84 Park, Cho, Chong, Lee, Choi, Jeong (CR9) 2010; 61 CR15 CR14 CR13 CR51 van Arkel, Boeree, Magis-Escurra, Hoefsloot, Carpaij, van Ingen (CR55) 2022; 3 Breen, Smith, Bettinson, Dart, Bannister, Johnson (CR3) 2004; 59 Ramos, Asensio, Perales, Montero, Martín (CR31) 2003; 22 Carter, Mates (CR34) 1994; 106 Namale, Abdullahi, Fine, Kamkuemah, Wilkinson, Meintjes (CR2) 2015; 10 Campbell, Ormerod, Friend, Jenkins, Prescott (CR16) 1993; 87 Shah, Borse (CR28) 2012; 40 Mert, Ozaras (CR30) 2004; 36 CR26 Meintjes, Lawn, Scano, Maartens, French, Worodria (CR1) 2008; 8 CR25 Yalçınsoy, Baran, Bilgin, Afşar, Celenk, Esen (CR29) 2013; 47 Perrin, Breen, Lipman, Shorten, Gillespie, McHugh (CR44) 2005; 60 CR24 Domínguez-Moreno, García-Grimshaw, Medina-Julio, Cantú-Brito, González-Duarte (CR54) 2022; 43 Worodria, Menten, Massinga-Loembe, Mazakpwe, Bagenda, Koole (CR21) 2012; 17 Huyst, Lynen, Bottieau, Zolfo, Kestens, Colebunders (CR35) 2007; 62 Sossen, Richards, Heinsohn, Frascella, Balzarini, Oradini-Alacreu (CR42) 2023; 11 van Loenhout-Rooyackers, Laheij, Richter, Verbeek (CR52) 2000; 15 Prasai, Joshi, Poudel, Sarjan, Pahari (CR27) 2023; 61 Coussens, Wilkinson, Nikolayevskyy, Elkington, Hanifa, Islam (CR43) 2013; 9 G Theron (2310_CR48) 2018; 56 2310_CR51 H Seok (2310_CR22) 2019; 19 JH van Loenhout-Rooyackers (2310_CR52) 2000; 15 T Saraya (2310_CR37) 2013; 52 A Machida (2310_CR23) 2018; 18 A Keeley (2310_CR56) 2020; 31 A Khurana (2310_CR46) 2021; 68 EJ Carter (2310_CR34) 1994; 106 C Brown (2310_CR7) 2016; 16 S Yu (2310_CR8) 2015; 19 P Prasai (2310_CR27) 2023; 61 A Jniene (2310_CR53) 2010; 58 2310_CR14 M Yalçınsoy (2310_CR29) 2013; 47 2310_CR13 2310_CR15 A Ramos (2310_CR31) 2003; 22 PE Namale (2310_CR2) 2015; 10 S Kondo (2310_CR11) 2006; 81 T Nakazono (2310_CR36) 1992; 67 G Meintjes (2310_CR1) 2008; 8 K Park (2310_CR9) 2010; 61 K Park (2310_CR20) 2013; 67 L Sarda-Mantel (2310_CR49) 2021; 8 V Huyst (2310_CR35) 2007; 62 C van Arkel (2310_CR55) 2022; 3 L Armange (2310_CR32) 2023; 42 IA Campbell (2310_CR16) 1993; 87 2310_CR25 2310_CR24 G Geri (2310_CR4) 2013; 41 2310_CR26 MJ Lee (2310_CR33) 2012; 24 G Yamada (2310_CR38) 2013; 7 R Domínguez-Moreno (2310_CR54) 2022; 43 SM Hermans (2310_CR47) 2021; 72 PK Drain (2310_CR41) 2018 W Worodria (2310_CR21) 2012; 17 A Mert (2310_CR30) 2004; 36 I Shah (2310_CR28) 2012; 40 Y Choi (2310_CR17) 2002; 224 A Polesky (2310_CR18) 2005; 84 DA Barr (2310_CR5) 2017; 21 A Okazaki (2310_CR40) 2016; 22 F Perrin (2310_CR44) 2005; 60 IA Campbell (2310_CR12) 1979; 60 C Hawkey (2310_CR19) 2005; 40 T Takao (2310_CR10) 2010; 48 M Rotaru (2310_CR39) 2015; 56 V Cheng (2310_CR6) 2002; 21 RA Breen (2310_CR3) 2004; 59 AK Coussens (2310_CR43) 2013; 9 IA Campbell (2310_CR45) 1990; 71 B Sossen (2310_CR42) 2023; 11 N Lefebvre (2310_CR50) 2017; 50
References_xml	– volume: 41 start-page: 537 year: 2013 end-page: 543 ident: CR4 article-title: Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients publication-title: Infection doi: 10.1007/s15010-012-0376-9 – volume: 43 start-page: 2699 year: 2022 end-page: 2708 ident: CR54 article-title: Paradoxical manifestations during tuberculous meningitis treatment among HIV-negative patients: a retrospective descriptive study and literature review publication-title: Neurolo Sci doi: 10.1007/s10072-021-05693-2 – volume: 58 start-page: 366 year: 2010 end-page: 374 ident: CR53 article-title: Epidemiological, therapeutic and evolutionary profiles in patients with lymph node tuberculosis publication-title: Tuberkuloz ve toraks – volume: 62 start-page: 126 year: 2007 end-page: 129 ident: CR35 article-title: Immune reconstitution inflammatory syndrome in an HIV/TB co-infected patient four years after starting antiretroviral therapy publication-title: Acta Clin Belg doi: 10.1179/acb.2007.022 – ident: CR51 – volume: 67 start-page: 408 year: 2013 end-page: 415 ident: CR20 article-title: Incidence and outcomes of paradoxical lymph node enlargement after anti-tuberculosis therapy in non-HIV patients publication-title: J Infect doi: 10.1016/j.jinf.2013.07.022 – volume: 16 start-page: 479 year: 2016 ident: CR7 article-title: Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control study publication-title: BMC Infect Dis doi: 10.1186/s12879-016-1816-4 – volume: 31 start-page: 808 year: 2020 end-page: 812 ident: CR56 article-title: Anakinra in the treatment of protracted paradoxical inflammatory reactions in HIV-associated tuberculosis in the United Kingdom: a report of two cases publication-title: Int J STD AIDS doi: 10.1177/0956462420915394 – volume: 17 start-page: 841 year: 2012 end-page: 848 ident: CR21 article-title: Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection publication-title: Antivir Ther doi: 10.3851/IMP2108 – volume: 10 start-page: 1077 year: 2015 end-page: 1099 ident: CR2 article-title: Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis publication-title: Future Microbiol doi: 10.2217/fmb.15.9 – volume: 87 start-page: 621 year: 1993 end-page: 623 ident: CR16 article-title: Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results publication-title: Respir Med doi: 10.1016/S0954-6111(05)80265-3 – volume: 42 start-page: 413 year: 2023 end-page: 422 ident: CR32 article-title: The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-023-04564-2 – volume: 11 start-page: 367 year: 2023 end-page: 379 ident: CR42 article-title: The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(23)00097-8 – ident: CR25 – volume: 71 start-page: 1 year: 1990 end-page: 3 ident: CR45 article-title: The treatment of superficial tuberculous lymphadenitis publication-title: Tubercle doi: 10.1016/0041-3879(90)90052-A – volume: 3 start-page: 603 year: 2022 end-page: 11e2 ident: CR55 article-title: Interleukin-1 receptor antagonist anakinra as treatment for paradoxical responses in HIV-negative tuberculosis patients: a case series publication-title: Med doi: 10.1016/j.medj.2022.07.001 – volume: 8 start-page: 516 year: 2008 end-page: 523 ident: CR1 article-title: Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(08)70184-1 – volume: 59 start-page: 704 year: 2004 end-page: 707 ident: CR3 article-title: Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection publication-title: Thorax doi: 10.1136/thx.2003.019224 – volume: 19 start-page: 1388 year: 2015 end-page: 1394 ident: CR8 article-title: Late paradoxical lymph node enlargement during and after anti-tuberculosis treatment in non-HIV-infected patients publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.15.0257 – volume: 81 start-page: 375 year: 2006 end-page: 379 ident: CR11 article-title: Three cases of tuberculosis children who demonstrated paradoxical worsening during different stage of treatment publication-title: Kekkaku – ident: CR15 – volume: 18 start-page: 313 year: 2018 ident: CR23 article-title: Late-onset paradoxical reactions 10 years after treatment for tuberculous meningitis in an HIV-negative patient: a case report publication-title: BMC Infect Dis doi: 10.1186/s12879-018-3229-z – volume: 60 start-page: 95 year: 1979 end-page: 98 ident: CR12 article-title: Lymph node tuberculosis: a comparison of treatments 18 months after completion of chemotherapy publication-title: Tubercle doi: 10.1016/0041-3879(79)90042-4 – volume: 84 start-page: 350 year: 2005 end-page: 362 ident: CR18 article-title: Peripheral tuberculous lymphadenitis: epidemiology, diagnosis, treatment, and outcome publication-title: Medicine doi: 10.1097/01.md.0000189090.52626.7a – volume: 48 start-page: 55 year: 2010 end-page: 59 ident: CR10 article-title: A case of multiple and metachronous pleural tuberculomas during the course of anti-tuberculous chemotherapy and follow-up of a caseous pneumonia publication-title: Nihon Kokyuki Gakkai Zasshi – volume: 21 start-page: 803 year: 2002 end-page: 809 ident: CR6 article-title: Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-002-0821-2 – ident: CR26 – volume: 224 start-page: 493 year: 2002 end-page: 502 ident: CR17 article-title: Tuberculous pleural effusion: new pulmonary lesions during treatment publication-title: Radiology doi: 10.1148/radiol.2242011280 – volume: 52 start-page: 2385 year: 2013 end-page: 2386 ident: CR37 article-title: Late-occurring paradoxical reaction masquerading as treatment failure for tuberculous adenitis publication-title: Intern Med doi: 10.2169/internalmedicine.52.0826 – volume: 15 start-page: 192 year: 2000 end-page: 195 ident: CR52 article-title: Shortening the duration of treatment for cervical tuberculous lymphadenitis publication-title: Eur Respir J doi: 10.1183/09031936.00.15119200 – volume: 61 start-page: 175 year: 2023 end-page: 178 ident: CR27 article-title: Cecal perforation following intraperitoneal abscess after anti-tubercular therapy: a case report publication-title: J Nepal Med Assoc doi: 10.31729/jnma.8042 – volume: 56 start-page: 569 year: 2015 end-page: 574 ident: CR39 article-title: An immunocompetent young patient with tuberculosis of the penis: a challenging case publication-title: Rom J Morphol Embryol – volume: 22 start-page: 374 year: 2003 end-page: 376 ident: CR31 article-title: Prolonged paradoxical reaction of tuberculosis in an HIV-infected patient after initiation of highly active antiretroviral therapy publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-003-0940-4 – volume: 7 start-page: 72 year: 2013 ident: CR38 article-title: Systemic lymph node tuberculosis presenting with an aseptic psoas abscess caused by a paradoxical reaction after nine months of antituberculosis treatment: a case report publication-title: J Med Case Rep doi: 10.1186/1752-1947-7-72 – ident: CR14 – volume: 21 start-page: 677 year: 2017 end-page: 683 ident: CR5 article-title: Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.16.0927 – volume: 24 start-page: 594 year: 2012 end-page: 599 ident: CR33 article-title: Diagnosis and treatment strategies of tuberculous intestinal perforations: a case series publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0b013e328350fd4a – volume: 61 start-page: 430 year: 2010 end-page: 434 ident: CR9 article-title: Post-therapy paradoxical response in immunocompetent patients with lymph node tuberculosis publication-title: J Infect doi: 10.1016/j.jinf.2010.08.011 – volume: 68 start-page: 215 year: 2021 end-page: 220 ident: CR46 article-title: Determinants of lymph node resolution in patients of tubercular lymphadenitis treated with anti tuberculous chemotherapy: a hospital based longitudinal study publication-title: Indian J Tuberc doi: 10.1016/j.ijtb.2020.08.009 – volume: 40 start-page: 15 year: 2012 end-page: 17 ident: CR28 article-title: Paradoxical tuberculomas after completion of antituberculous treatment publication-title: Trop Med Health doi: 10.2149/tmh.2012-09 – volume: 67 start-page: 449 year: 1992 end-page: 456 ident: CR36 article-title: A radiographic progression during and after initial chemotherapy for pulmonary tuberculosis publication-title: Kekkaku – year: 2018 ident: CR41 article-title: Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00021-18 – volume: 36 start-page: 78 year: 2004 end-page: 79 ident: CR30 article-title: Paradoxical reaction: can it be seen after completion of the anti-tuberculous therapy? publication-title: Scand J Infect Dis doi: 10.1080/00365540310017267 – volume: 72 start-page: 1919 year: 2021 end-page: 1926 ident: CR47 article-title: High rates of recurrent tuberculosis disease: a population-level cohort study publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa470 – volume: 60 start-page: 706 year: 2005 end-page: 707 ident: CR44 article-title: Is there a relationship between strain type and TB paradoxical reaction? publication-title: Thorax doi: 10.1136/thx.2005.044321 – volume: 8 year: 2021 ident: CR49 article-title: [(18) F]FDG positron emission tomography for initial staging and healing assessment at the end of therapy in lymph nodes and bone tuberculosis publication-title: Front Med (Lausanne) doi: 10.3389/fmed.2021.715115 – volume: 22 start-page: 748 year: 2016 end-page: 751 ident: CR40 article-title: Paradoxical reaction to antituberculosis therapy after 6 months of treatment for pulmonary tuberculosis: a case report publication-title: J Infect Chemother doi: 10.1016/j.jiac.2016.03.012 – ident: CR13 – volume: 56 start-page: e01696-17 year: 2018 ident: CR48 article-title: False-positive Xpert MTB/RIF results in retested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes publication-title: J Clin Microbiol doi: 10.1128/JCM.01696-17 – volume: 9 year: 2013 ident: CR43 article-title: Ethnic variation in inflammatory profile in tuberculosis publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1003468 – volume: 50 start-page: 17 year: 2017 end-page: 24 ident: CR50 article-title: Clinical usefulness of (18)F-FDG PET/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis publication-title: Nucl Med Biol doi: 10.1016/j.nucmedbio.2017.04.003 – volume: 40 start-page: 1368 year: 2005 end-page: 1371 ident: CR19 article-title: Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis publication-title: Clin Infect Dis doi: 10.1086/429317 – volume: 106 start-page: 1896 year: 1994 end-page: 1898 ident: CR34 article-title: Sudden enlargement of a deep cervical lymph node during and after treatment for pulmonary tuberculosis publication-title: Chest doi: 10.1378/chest.106.6.1896 – volume: 19 start-page: 867 year: 2019 ident: CR22 article-title: Characteristics of residual lymph nodes after six months of antituberculous therapy in HIV-negative individuals with cervical tuberculous lymphadenitis publication-title: BMC Infect Dis doi: 10.1186/s12879-019-4507-0 – volume: 47 start-page: 385 year: 2013 end-page: 387 ident: CR29 article-title: Increase in size of lymph nodes or occurrence of new lymphadenopathy during antituberculosis chemotherapy: paradoxical response publication-title: Mikrobiyol Bul doi: 10.5578/mb.4358 – ident: CR24 – volume: 21 start-page: 677 year: 2017 ident: 2310_CR5 publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.16.0927 – volume: 10 start-page: 1077 year: 2015 ident: 2310_CR2 publication-title: Future Microbiol doi: 10.2217/fmb.15.9 – volume: 9 year: 2013 ident: 2310_CR43 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1003468 – volume: 106 start-page: 1896 year: 1994 ident: 2310_CR34 publication-title: Chest doi: 10.1378/chest.106.6.1896 – volume: 68 start-page: 215 year: 2021 ident: 2310_CR46 publication-title: Indian J Tuberc doi: 10.1016/j.ijtb.2020.08.009 – volume: 67 start-page: 449 year: 1992 ident: 2310_CR36 publication-title: Kekkaku – volume: 40 start-page: 15 year: 2012 ident: 2310_CR28 publication-title: Trop Med Health doi: 10.2149/tmh.2012-09 – ident: 2310_CR13 doi: 10.1016/0007-0971(84)90165-7 – volume: 31 start-page: 808 year: 2020 ident: 2310_CR56 publication-title: Int J STD AIDS doi: 10.1177/0956462420915394 – volume: 224 start-page: 493 year: 2002 ident: 2310_CR17 publication-title: Radiology doi: 10.1148/radiol.2242011280 – volume: 16 start-page: 479 year: 2016 ident: 2310_CR7 publication-title: BMC Infect Dis doi: 10.1186/s12879-016-1816-4 – volume: 17 start-page: 841 year: 2012 ident: 2310_CR21 publication-title: Antivir Ther doi: 10.3851/IMP2108 – volume: 19 start-page: 867 year: 2019 ident: 2310_CR22 publication-title: BMC Infect Dis doi: 10.1186/s12879-019-4507-0 – volume: 19 start-page: 1388 year: 2015 ident: 2310_CR8 publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.15.0257 – volume: 36 start-page: 78 year: 2004 ident: 2310_CR30 publication-title: Scand J Infect Dis doi: 10.1080/00365540310017267 – volume: 56 start-page: 569 year: 2015 ident: 2310_CR39 publication-title: Rom J Morphol Embryol – volume: 71 start-page: 1 year: 1990 ident: 2310_CR45 publication-title: Tubercle doi: 10.1016/0041-3879(90)90052-A – volume: 62 start-page: 126 year: 2007 ident: 2310_CR35 publication-title: Acta Clin Belg doi: 10.1179/acb.2007.022 – volume: 8 year: 2021 ident: 2310_CR49 publication-title: Front Med (Lausanne) doi: 10.3389/fmed.2021.715115 – volume: 21 start-page: 803 year: 2002 ident: 2310_CR6 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-002-0821-2 – volume: 72 start-page: 1919 year: 2021 ident: 2310_CR47 publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa470 – volume: 42 start-page: 413 year: 2023 ident: 2310_CR32 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-023-04564-2 – volume: 50 start-page: 17 year: 2017 ident: 2310_CR50 publication-title: Nucl Med Biol doi: 10.1016/j.nucmedbio.2017.04.003 – volume: 24 start-page: 594 year: 2012 ident: 2310_CR33 publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0b013e328350fd4a – volume: 22 start-page: 374 year: 2003 ident: 2310_CR31 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-003-0940-4 – volume: 43 start-page: 2699 year: 2022 ident: 2310_CR54 publication-title: Neurolo Sci doi: 10.1007/s10072-021-05693-2 – volume: 22 start-page: 748 year: 2016 ident: 2310_CR40 publication-title: J Infect Chemother doi: 10.1016/j.jiac.2016.03.012 – volume: 47 start-page: 385 year: 2013 ident: 2310_CR29 publication-title: Mikrobiyol Bul doi: 10.5578/mb.4358 – volume: 59 start-page: 704 year: 2004 ident: 2310_CR3 publication-title: Thorax doi: 10.1136/thx.2003.019224 – volume: 56 start-page: e01696-17 year: 2018 ident: 2310_CR48 publication-title: J Clin Microbiol doi: 10.1128/JCM.01696-17 – volume: 58 start-page: 366 year: 2010 ident: 2310_CR53 publication-title: Tuberkuloz ve toraks – volume: 81 start-page: 375 year: 2006 ident: 2310_CR11 publication-title: Kekkaku – volume: 84 start-page: 350 year: 2005 ident: 2310_CR18 publication-title: Medicine doi: 10.1097/01.md.0000189090.52626.7a – volume: 61 start-page: 430 year: 2010 ident: 2310_CR9 publication-title: J Infect doi: 10.1016/j.jinf.2010.08.011 – ident: 2310_CR25 doi: 10.1136/bcr-2012-006262 – volume: 67 start-page: 408 year: 2013 ident: 2310_CR20 publication-title: J Infect doi: 10.1016/j.jinf.2013.07.022 – ident: 2310_CR26 doi: 10.2176/nmc.44.133 – volume: 7 start-page: 72 year: 2013 ident: 2310_CR38 publication-title: J Med Case Rep doi: 10.1186/1752-1947-7-72 – ident: 2310_CR14 doi: 10.1136/bmj.290.6475.1106 – year: 2018 ident: 2310_CR41 publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00021-18 – volume: 40 start-page: 1368 year: 2005 ident: 2310_CR19 publication-title: Clin Infect Dis doi: 10.1086/429317 – ident: 2310_CR24 doi: 10.1177/2325957413488170 – volume: 48 start-page: 55 year: 2010 ident: 2310_CR10 publication-title: Nihon Kokyuki Gakkai Zasshi – volume: 61 start-page: 175 year: 2023 ident: 2310_CR27 publication-title: J Nepal Med Assoc doi: 10.31729/jnma.8042 – volume: 52 start-page: 2385 year: 2013 ident: 2310_CR37 publication-title: Intern Med doi: 10.2169/internalmedicine.52.0826 – volume: 41 start-page: 537 year: 2013 ident: 2310_CR4 publication-title: Infection doi: 10.1007/s15010-012-0376-9 – volume: 8 start-page: 516 year: 2008 ident: 2310_CR1 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(08)70184-1 – volume: 60 start-page: 95 year: 1979 ident: 2310_CR12 publication-title: Tubercle doi: 10.1016/0041-3879(79)90042-4 – volume: 18 start-page: 313 year: 2018 ident: 2310_CR23 publication-title: BMC Infect Dis doi: 10.1186/s12879-018-3229-z – volume: 60 start-page: 706 year: 2005 ident: 2310_CR44 publication-title: Thorax doi: 10.1136/thx.2005.044321 – volume: 15 start-page: 192 year: 2000 ident: 2310_CR52 publication-title: Eur Respir J doi: 10.1183/09031936.00.15119200 – ident: 2310_CR51 doi: 10.1101/2023.04.03.535218 – volume: 3 start-page: 603 year: 2022 ident: 2310_CR55 publication-title: Med doi: 10.1016/j.medj.2022.07.001 – volume: 87 start-page: 621 year: 1993 ident: 2310_CR16 publication-title: Respir Med doi: 10.1016/S0954-6111(05)80265-3 – ident: 2310_CR15 doi: 10.1016/0007-0971(88)90069-1 – volume: 11 start-page: 367 year: 2023 ident: 2310_CR42 publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(23)00097-8
SSID	ssj0005947
Score	2.4288938
SecondaryResourceType	review_article
Snippet	Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during treatment, but have also been described after treatment. A presentation with...
SourceID	pubmedcentral proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	2083
SubjectTerms	Antitubercular Agents - therapeutic use Central nervous system Chemical synthesis Diagnosis Epidemiology Family Medicine Female General Practice Humans Incidence Infectious Diseases Inflammation Internal Medicine Lymph nodes Male Medicine Medicine & Public Health Recurrence Review Signs and symptoms Tuberculosis Tuberculosis - diagnosis Tuberculosis - drug therapy Tuberculosis - epidemiology Tuberculosis, Lymph Node - diagnosis Tuberculosis, Lymph Node - drug therapy
SummonAdditionalLinks	– databaseName: Springer dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8NAEB60ivjifUSrRPBNF3Jsks2jiMUXi3jRt5DsgYWSSNOKP9_ZbQ5qVdC3kEw2uzO7mfmYC-AcYU-oWzoQx2ecUEUlyRzFSJapNFaBT1XITbOJqN9ng0F8XyWFlXW0e-2SNH_qNtktMI5bjxJdswyvlmEF1R3TDRseHl_awI7YtBXD3esQVF9hlSrz_Rjz6mjBxlwMlfziLzVqqLf5vwVswUZldtpXs32yDUsy34G1u8qxvguubtpLJtNMjvl0VJTD0m5C0G1dHlwUH1qcNt40mRDlHjz3bp6ub0nVTYFwGgUTQpmkwnUFRzFEWcBl6iP8YIIqJ1KIuhBY8DhyheenAlEVCxCJpEqhwDJP6fzTfejkRS4PwWa-G6JZEkZCMEpFmIaBl0aORNvXiXBpFrg1UxNelRrXHS9GSVskWfMiQV4khheJY8FF887brNDGr9TdWlZJdejKxHf1tD20GS04ax7jcdE-kDSXxRRp0ETyESP5sQUHM9E2n0PbTddfw8HZnNAbAl2Ke_5JPnw1JbkRVcYx2rYWXNayb-f18zKO_kZ-DOue3j4mlrALncl4Kk9glb9PhuX41JyCTxfG_qw priority: 102 providerName: Springer Nature
Title	Post-tuberculosis treatment paradoxical reactions
URI	https://link.springer.com/article/10.1007/s15010-024-02310-0 https://www.ncbi.nlm.nih.gov/pubmed/38955990 https://www.proquest.com/docview/3119852951 https://www.proquest.com/docview/3075375839 https://pubmed.ncbi.nlm.nih.gov/PMC11499416
Volume	52
WOSCitedRecordID	wos001261194200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1439-0973 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0005947 issn: 0300-8126 databaseCode: 7X7 dateStart: 20230101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1439-0973 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0005947 issn: 0300-8126 databaseCode: BENPR dateStart: 20230101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. customDbUrl: eissn: 1439-0973 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0005947 issn: 0300-8126 databaseCode: 7RV dateStart: 20230101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1439-0973 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0005947 issn: 0300-8126 databaseCode: 8C1 dateStart: 20230101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVAVX databaseName: Springer LINK customDbUrl: eissn: 1439-0973 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0005947 issn: 0300-8126 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LbtQwcARthbjwaIEGSpVK3FqLOHFi54SgasWFVbWUam9R4oe6UpWUzW7F5zPj9Wa1reiFi5XETmLPjO0ZzwvgE4o9BaV0YEmmNBNOWNYkTrGmcXXp8ky4QvtkE3I0UpNJeREO3PpgVrlaE_1CbTpNZ-SfM47iMWml-Jfb34yyRpF2NaTQeArbnHhjpGc5vlqbeJQ-wRjSccJwIyuC08zSdS73auBUMIqAhlebG9MDbvOh0eQ9zanfkM5f_u9QXsGLwIrGX5e08xqe2HYXnv0IyvY94JTIl80XjZ3pxU3XT_t4MEuPKWS46f4QimN86L0j-jfw6_zs8vQ7CxkWmBYynzOhrDCcG42okU2ubZ2hSKKMcIl0KImhsKFLyU2a1aagTqN0UjuHSGxSRz6pb2Gr7Vq7D7HKeIGsSiGNUUKYoi7ytJaJRX44kQjhCPgKvJUO4ccpC8ZNtQ6cTCipECWVR0mVRHA8vHO7DL7xaOuDFbirMBH7ag3rCI6GapxCpBepW9stsA2yTRnKTVkZwbslkoffIT9HMdnw42oD_UMDCs-9WdNOr32YbpQ0yxL53QhOVpSy7te_h_H-8WF8gOcpUa23JzyArflsYT_Cjr6bT_vZoad_KifSlwpLdcoPYfvb2ehijHfjn1d_AVxQDoQ
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9tAEB4BRaWXttCWugVqpHKCVf1Ye-1DVVUFBAIiDiDlZux9qJGQTeOkjz_V39iZ9SNKEdw4cIvitb32fDv7jecF8BHNnphaOjAvTCTjhmtWeCZhRWHy1EQhN7G0zSbEYJAMh-n5AvztcmEorLLTiVZRq0rSN_JPoY_mMXml_C83Pxh1jSLvatdCo4HFif7zC022-vPxPsp3JwgODy6-HbG2qwCTXEQTxhPNle8ridMRRSR1HiINTxQ3njBofSDBlqnwVRDmKqZ7IiPPjcGJF4GhPEy87iI8QT0uyNgTQzELKUltQzNcNx7DjTNuk3SaVL3Iup0DzqjiGv6a3whvsdvbQZr_eWrtBnj44rG9upfwvKXa7tdmbazCgi7X4OlZG0zwCnxqVMwm00KP5fS6qke124fdu1QSXVW_CcIu_mmzP-rXcPkgE34DS2VV6rfgJqEfIxWLhVIJ5yrO4yjIhaeR73sCJeqA34kzk215derycZ3NCkMTBDKEQGYhkHkO7Pbn3DTFRe4dvdGJN2sVTZ3NZOvAdn8YVQT5ffJSV1Mcg7QwRLswTB1Yb0DV3w75KtWcw4snc3DrB1D58fkj5ei7LUOOlnSaIp93YK9D5mxedz_Gu_sf4wOsHF2cnWanx4OT9_AsoBVjYyc3YGkynupNWJY_J6N6vGXXngtXD43Yf74pZgY
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgiouvKGBAkGCE1hNYsdxDgihlhVVYdUDSL2FxA-xUpW0m10ef41fx4zzWJaK3nrgFiVOYmc-299kXgDPUe2RVNKBRVxpJpywrIqcYlXlytylXDipfbGJbDpVx8f50Qb8GmJhyK1yWBP9Qm0aTf_Id3mM6jFZpeJd17tFHO1P3pyeMaogRZbWoZxGB5FD-_M7qm_t64N9lPWLJJm8-7T3nvUVBpgWWbpgQllh4tho7FpWpdqWHCm5MsJFmUNNBMm2zrPYJLw0kt6P7Lx0DgdRJY5iMvG5V-BqxiUnxU_t_eFekvviZjiHIoabqOwDdrqwvdSboBPBKPsaHq1viueY7nmHzb-stn4znNz8nz_jLbjRU_DwbTdnbsOGre_A1sfeyeAuxFTAmC2WlZ3r5UnTztpwdMcPKVW6aX4QtEM86aNC2nvw-VI6fB8266a22xAqHkukaDIzRglhZCnTpMwii3pAlKF0A4gH0Ra6T7tO1T9OilXCaIJDgXAoPByKKICX4z2nXdKRC1vvDKIu-gWoLVZyDuDZeBmXDrIHlbVtltgG6SJHfZHnATzoADa-Dnks5aLDh6s16I0NKC35-pV69tWnJ0cNO8-R5wfwakDpql__HsbDi4fxFLYQqMWHg-nhI7ie0OTxLpU7sLmYL-1juKa_LWbt_ImfhiF8uWzA_garBG6N
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Post-tuberculosis+treatment+paradoxical+reactions&rft.jtitle=Infection&rft.au=Hermans%2C+Sabine+M&rft.au=Akkerman%2C+Onno+W&rft.au=Meintjes%2C+Graeme&rft.au=Grobusch%2C+Martin+P&rft.date=2024-10-01&rft.issn=1439-0973&rft.eissn=1439-0973&rft.volume=52&rft.issue=5&rft.spage=2083&rft_id=info:doi/10.1007%2Fs15010-024-02310-0&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-8126&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-8126&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-8126&client=summon